Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mammograms and mortality

This article was originally published in The Gray Sheet

Executive Summary

National Cancer Institute's physician data query (PDQ) editorial board has concluded that a study performed by Nordic Cochrane Center in Denmark to evaluate mammography screening may have merit. The study, originally released in 2000, questioned the value of mammography in reducing breast cancer mortality rates. NCI's independent advisory panel has not yet issued a report on the subject, but the institute is unlikely in the near future to change its breast cancer screening guidelines, which recommend regular screening of women over 50. NCI maintains that early detection is important to cancer control and says that mammorgraphy may be beneficial to women ages 40-49...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel